Dec 10, 2018 - Amgen (AMGN) hikes its quarterly dividend by 10%.
Dec 07, 2018 - Adamis and Sandoz announce an expected SYMJEPI launch in Q1 2019.Sandoz announces SYMJEPI’s WAC of $250 vs. $300 for Mylan’s and Teva’s generic EpiPen.Adamis has completed manufacturing, and is shippi
Dec 07, 2018 - Conatus Pharmaceuticals didn't meet primary endpoint for phase 2b ENCORE-PH study, but a subgroup analysis of compensated cirrhosis patients had a clinically meaningful effect when taking emricasan.Th
Dec 07, 2018 - Novartis (NVS) presents supplementary data from phase III study on BYL719 in combination with Faslodex for the treatment of advanced breast cancer. The study scripts success in PFS.
Dec 07, 2018 - Glaxo (GSK) to buy TESARO and divest Horlicks brand to Unilever. ASH cancer presentations grab headilines.
Dec 06, 2018 - Celgene announces positive preliminary data from its study treating patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) using JCAR017.A key risk i
Dec 06, 2018 - THW is a Tekla healthcare fund much like THQ, but with an emphasis on holding global securities.THW currently has a quite attractive 10.55% yield.This fund is also showing a discount of 8.29%, but tha
Dec 04, 2018 - Eye Drug Continues to Drive Regeneron's Growth, Stocks: REGN,NVS,RHHBY,XTER:BAYN,IBB,RGNY,APLS,OPHT,AGN, release date:Dec 04, 2018
Dec 04, 2018 - Incyte (INCY) announces positive data on lead drug Jakafi at the ASH meet for the indication of acute GVHD.
Dec 04, 2018 - Gilead (GILD) announces data on chimeric antigen receptor T (CAR T) cell therapy candidate at the ASH for the treatment of patients with relapsed or refractory acute lymphoblastic leukemia.